Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Daily Market Overview Sp 500 Nasdaq Edge Higher Dow Posts Slight Dip 20260403 1 The credit profile of BioGreen Med BGMS revealed Q3 2024 EPS Beats Forecasts Is Nextpower NXT stock showing technical weakness Q1 2026 EPS Beats Forecasts How GIII GIII manages tail risk exposure Q1 2026 Earnings Underperform Why Real Asset RAAQW ability to execute stands out 167 20260508 The Federal Reserve Is Quickly Running Out of Reasons to Cut Interest Rates Skillz Inc SKLZ Surges Over 15 as Trading Volume Spikes April Jobs Report Modest Payroll Growth Expected as Labor Market Cools Red Light Therapy Gains Traction as a Wellness Trend Drawing Investor Interest Costcos SameStore Sales Surge 98 in Q3 Fueled by Higher Gasoline Prices and Membership Appeal Rupee Strengthens for Third Session on Oil Slump and RBI Support Closes at 9523 per Dollar Wall Street Hits New Highs as AI Rally Takes a Breather Tracker Mortgages Regain Popularity Amid Uncertain Rate Outlook Evaluating the Pros and Cons Lowes Companies LOW Faces Price Target Reduction Amidst Market Adjustments Thousands of Stock Trades Linked to President Trump Draw Scrutiny Fortive Q1 2026 Earnings Strong EPS Beat Bolsters Investor Confidence CubeSmart Q1 2026 Earnings Slight EPS Beat Amid Steady SelfStorage Demand Genpact G Q1 2026 Earnings EPS Beat Highlights Resilient Operations Amid Market Caution Performance Shipping Inc PSHG Q4 2025 Earnings Earnings Beat Despite Negative Stock Reaction AGIO Q1 2026 Earnings Narrower Loss Per Share Highlights Improving Cost Management TCMD Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares Founder Group Limited FGL Slides 20 as Selling Pressure Intensifies DTW Inches Higher Amid FixedIncome Stability Debenture Holds Steady at 2116 Kura Oncology Stock Slides Testing Key Support Levels Amid Biotech Sector Weakness Antalpha Platform Holding ANTA Holds Steady at 802 as Market Awaits Catalyst Genenta Science GNTA Surges 69 as Biotechnology Stock Tests Key Resistance Levels